Literature DB >> 6421112

DL-threo-3,4-dihydroxyphenylserine for freezing symptom in parkinsonism.

H Narabayashi, T Kondo, T Nagatsu, A Hayashi, T Suzuki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421112

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


× No keyword cloud information.
  6 in total

1.  Cerebrospinal fluid catecholamine levels in Japanese encephalitis patients with movement disorders.

Authors:  U K Misra; J Kalita; S Pandey; V K Khanna; G Nagesh Babu
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

Review 2.  Current drug therapy for Parkinson's disease. A review.

Authors:  R J Coleman
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

3.  Low-dose dexamethasone suppression test in Japanese patients with Parkinson's disease.

Authors:  T Kawamura; M Kinoshita; Y Iwasaki; H Nemoto
Journal:  J Neurol       Date:  1987-05       Impact factor: 4.849

4.  Cognitive and Behavioral Changes in Patients Treated With Droxidopa for Neurogenic Orthostatic Hypotension: A Retrospective Review.

Authors:  Katherine E McDonell; Cyndya A Shibao; Italo Biaggioni; Adam Hartman; David Robertson; Daniel O Claassen
Journal:  Cogn Behav Neurol       Date:  2019-09       Impact factor: 1.600

5.  Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.

Authors:  Christopher J Barnum; Nirmal Bhide; David Lindenbach; Margaret A Surrena; Adam A Goldenberg; Stefanie Tignor; Anna Klioueva; Hannah Walters; Christopher Bishop
Journal:  Pharmacol Biochem Behav       Date:  2011-09-25       Impact factor: 3.533

6.  Memory effect of DL-threo-3,4-dihydroxyphenylserine (DOPS) in human Korsakoff's disease.

Authors:  P J Langlais; R G Mair; P J Whalen; W McCourt; W J McEntee
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.